Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Nsclc'

Nsclc published presentations and documents on DocSlides.

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

  • stefany-barnette
  • 30 Slides

Renato G. Martins, MD, MPH. Medical Director, Tho...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

  • ellena-manuel
  • 0 Slides

Jared Weiss, MD . Assistant . Professor of Medici...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

  • sherrill-nordquist
  • 0 Slides

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

  • debby-jeon
  • 0 Slides

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

  • everly
  • 14 Slides

Professor Rachel Butler. The genomic complexity of...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

  • sawyer742
  • 5 Slides

Intervista a Federico . Cappuzzo. Background:. Pr...

Michael

Michael

  • luanne-stotts
  • 62 Slides

Brada. . Torino. . 6 March 2015. Perspectives...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

  • debby-jeon
  • 30 Slides

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

David R.

David R.

  • alida-meadow
  • 47 Slides

Gandara. , MD. University of California, Davis . ...

Thierry

Thierry

  • cheryl-pisano
  • 40 Slides

Le Chevalier, . MD. The Role of Translational Res...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

  • ellena-manuel
  • 48 Slides

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

  • test
  • 5 Slides

Intervista a Federico . Cappuzzo. Background:. P...

James Yang,

James Yang,

  • pasty-toler
  • 93 Slides

MD. The Evolving Treatment Landscape in NSCLC: Co...

Comparision

Comparision

  • jane-oiler
  • 33 Slides

of the expression of . 17-beta-hydroxysteroid . ...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

  • pasty-toler
  • 0 Slides

This program will include a discussion of off-lab...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

  • luanne-stotts
  • 25 Slides

The Role of Antiangiogenic Agents in the Changin...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

  • stefany-barnette
  • 15 Slides

The Cancer genome atlas (TCGA) and the search for...

Please note, these are the

Please note, these are the

  • disclaimercanon
  • 72 Slides

actual. . video-recorded proceedings from the . l...

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

  • southan
  • 67 Slides

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

  • chaptoe
  • 71 Slides

proceedings from the live CME event and may includ...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

  • scarlett
  • 15 Slides

NSCLC, non-small cell lung cancer.. Lung cancer in...

Beth Sandy, MSN, CRNP Nurse Practitioner

Beth Sandy, MSN, CRNP Nurse Practitioner

  • PriceOfFreedom
  • 57 Slides

Abramson Cancer Center . University of Pennsylvani...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

  • elena
  • 65 Slides

Kamil Konopka. Department of Oncology, University ...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

  • oconnor
  • 49 Slides

. 5. th. most commonly diagnosed cancer in Austra...

Consensus or Controversy?  

Consensus or Controversy?  

  • okelly
  • 109 Slides

Addressing Practical Clinical Questions Across the...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • karlyn-bohler
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Slides last updated:

Slides last updated:

  • calandra-battersby
  • 7 Slides

October 2013. There are two main types of lung . ...

Lung malignancy

Lung malignancy

  • tawny-fly
  • 17 Slides

Dr. Rachel Cary, FY1 Warwick Hospital. Learning ...

Targeting KRAS and down streaming

Targeting KRAS and down streaming

  • alexa-scheidler
  • 51 Slides

pathways. Federico Cappuzzo. Istituto Toscano Tum...

Terapia

Terapia

  • min-jolicoeur
  • 40 Slides

targeted. : . limiti e successi nelle metastasi ...

Detection of Mutations in EGFR in Circulating Lung-Cancer C

Detection of Mutations in EGFR in Circulating Lung-Cancer C

  • sherrill-nordquist
  • 12 Slides

Colin Reisterer and Nick Swenson. S. . Maheswaran...

Second line

Second line

  • alida-meadow
  • 66 Slides

treatments. in WT . pts. : . which. . opportuni...

Slides last updated:

Slides last updated:

  • stefany-barnette
  • 25 Slides

October 2013 . Ferlay . J, Shin HR, Bray F, Forma...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • pamella-moone
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Italian cohort of

Italian cohort of

  • test
  • 3 Slides

nivolumab. Expanded Access . Programme. (EAP): ...

Minesh Mehta, Northwestern University

Minesh Mehta, Northwestern University

  • mitsue-stanley
  • 40 Slides

Chicago, IL. Radiation for Prevention and Treatme...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

  • cheryl-pisano
  • 43 Slides

Giorgio V. Scagliotti. University. of . Torino,....

L’algoritmo terapeutico

L’algoritmo terapeutico

  • calandra-battersby
  • 26 Slides

attraverso . i . c. asi clinici. Giuseppe . Valma...

Estimated costs of managing treatment-related adverse

Estimated costs of managing treatment-related adverse

  • lindy-dunigan
  • 8 Slides

eventsof. . nivolumab. and . docetaxel. in the...

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

  • olivia-moreira
  • 32 Slides

Low TPS High TPS TPS = PD-L1 tumor proportion sco...

Copyright © 2024 DocSlides. All Rights Reserved